HealthMode, Inc. (healthmode.com) powers next-generation clinical trials and works toward regulatory approval and market access for drugs, devices, and combination products by developing and delivering AI-enabled digital measurement methods for clinical trials and clinical care.
HealthMode’s client partners represent a diverse set of stakeholders including drug developers at large pharmaceutical companies, clinical researchers and practitioners at academic medical centers, and startups entering the space with novel capabilities.
HealthMode’s measurement techniques:
- Improve understanding of phenotype
- Streamline and provide assurance for screening and eligibility;
- Provide early detection and mitigation of adverse events; and
- Serve as sensitive, specific, objective, and low burden endpoints.
The HealthMode approach allows for meaningful integration of clinical trial data with real-world evidence and provides the basis for movement toward a patient-specific understanding of health and wellness.
Partner with us to:
Introduce continuous representative data collection
Ensure high frequency measurement to detect meaningful clinical change
Incorporate objective assessment of therapeutic progression & minimise subjectivity
Understand causal relationships between genetics, environment & disease
Minimise the gap between real world & clinical trials data
Model individual disease trajectory & precisely predict prognosis
Partner to co-develop digital solutions for evidence generation in your clinical trials
Improve your research with our data modelling & product development capabilities
Participate in ground breaking remote research
- Unique capabilities in the development of digital measures
- Exceptional machine learning, artificial intelligence
- Agility in the execution of studies & collaboration with clinical sites worldwide
- Regulatory & market access expertise in multiple geographies
What's your greatest clinical trial design challenge?
Let's collaborate to develop a solution